Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019.
Amil Raj AgarwalJordan S CohenAlexis JorgensenSavyasachi C ThakkarUmasuthan SrikumaranGregory J GolladayPublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2022)
Besides the overall low utilization rate of osteoporosis treatment in patients following fragility fractures, there has been no change in the treatment utilization rate within the past decade. More resources and interventions need to be enforced for all providers managing these patients if we are ever to address the osteoporosis epidemic.